Everence Capital Management’s Core Laboratories CLB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13,420	Closed	-$155K	–	814
2025 Q2	$155K	Buy	+13,420	New	+$159K	0.01%	770
2024 Q3	–	Sell	-42,210	Closed	-$667	–	766
2024 Q2	$667	Hold	42,210	–	–	0.05%	306
2024 Q1	$721	Hold	42,210	–	–	0.05%	296
2023 Q4	$745K	Hold	42,210	–	–	0.05%	283
2023 Q3	$1.01K	Sell	42,210 -9,650	-19%	-$237K	0.08%	210
2023 Q2	$1.13M	Hold	51,860	–	–	0.09%	187
2023 Q1	$1.14K	Hold	51,860	–	–	0.09%	188
2022 Q4	$1.05K	Sell	51,860 -10,580	-17%	-$205K	0.09%	191
2022 Q3	$842K	Buy	62,440 +14,450	+30%	+$244K	0.08%	223
2022 Q2	$951K	Buy	47,990 +7,610	+19%	+$202K	0.08%	193
2022 Q1	$1.28M	Sell	40,380 -10,600	-21%	-$297K	0.1%	172
2021 Q4	$1.14M	Buy	50,980 +11,310	+29%	+$295K	0.08%	201
2021 Q3	$1.1M	Buy	39,670 +180	+0.5%	+$5.48K	0.09%	185
2021 Q2	$1.54M	Hold	39,490	–	–	0.13%	134
2021 Q1	$1.14M	Sell	39,490 -12,040	-23%	-$411K	0.1%	166
2020 Q4	$1.37M	Buy	51,530 +12,170	+31%	+$249K	0.13%	131
2020 Q3	$601K	Buy	39,360 +26,640	+209%	+$559K	0.07%	238
2020 Q2	$257K	Buy	+12,720	New	+$228K	0.03%	499